Cravatex Limited is an Indian listed entity that has undergone a significant strategic pivot to become a lean, **debt-free** holding and operating company. Following the divestment of its domestic branded sports and wellness business in late **2022**, the company now focuses on **textile trading**, **real estate leasing**, and the management of international sportswear brands through its European subsidiaries. The company is a subsidiary of **R.B. Fitness and Trading Private Limited**. --- ### **Core Revenue Pillars & Business Model** The company’s financial structure is supported by three distinct income streams, providing a blend of operational growth and stable cash flows: * **Textile and Garment Trading:** This is the primary operational driver. The company engages in the trading of various textile goods and garments. While this segment saw significant growth in the first three quarters of **FY 2024-25**, it remains sensitive to seasonal trends and global demand. * **Real Estate Leasing:** Cravatex generates steady, high-margin revenue from leasing premium office properties in **Mumbai**. A key milestone was reached in **June 2023**, when major properties in **Nariman Point** and **Prabhadevi** were successfully unencumbered following the release of all bank mortgages. * **International Dividend Inflows:** The company receives substantial dividends from its wholly-owned UK subsidiary. In **FY 2024-25**, dividend income rose sharply to **INR 432.30 Lacs**, compared to **INR 230.63 Lacs** the previous year, representing a **28% increase** in "Other Income." --- ### **International Brand Portfolio & Subsidiary Operations** Cravatex operates a robust international distribution and design network through its subsidiaries, focusing on iconic sportswear brands. | Entity | Relationship | Location | Principal Activity | |:---|:---|:---|:---| | **BB (UK) Limited (BBUK)** | Wholly-owned Subsidiary | United Kingdom | Design, sourcing, and marketing of **FILA** and **Sergio Tacchini**. | | **BB Euro GmbH** | Wholly-owned Step-down Subsidiary | Germany | Distribution and brand operations within the European market. | **BBUK** holds the exclusive license for **FILA** in the **UK and Middle East**, and the **Sergio Tacchini** license for the **UK**. Despite global macroeconomic headwinds that saw BBUK’s turnover drop from **GBP 1.93 crore** to **GBP 1.57 crore** in **FY 2024-25**, the subsidiary remained profitable due to stringent cost controls, posting a **Profit After Tax of GBP 361,000**. --- ### **Financial Performance & Capital Allocation** The company’s balance sheet was transformed by the **November 30, 2022**, sale of **Cravatex Brands Limited (CBL)** to Metro Brands Limited for **INR 9.99 crore**. This exit from the domestic branded footwear and wellness equipment sector allowed the company to eliminate all debt. **Key Financial Metrics:** | Metric | FY 2024-25 | FY 2023-24 | |:---|:---|:---| | **Net Profit (Lacs)** | **482.84** | **482.76** | | **Earnings Per Share (Rs.)** | **18.68** | **18.68** | | **Dividend Per Share (Rs.)** | **12.50 (125%)** | **3.00 (30%)** | | **Total Dividend Outflow** | **3.23 Crore** | **78 Lakhs** | | **Debt-Equity Ratio** | **0.00 (Debt Free)** | **0.00 (Debt Free)** | **Liquidity and Asset Management:** * **Investment Strategy:** Surplus funds, largely derived from international dividends, are deployed into high-rated **Mutual Funds**, totaling **1,589.33 Lacs** as of March 2025. * **Working Capital:** The **Debtors Turnover Ratio** improved in 2025 as year-end receivables were almost entirely realized. The company maintains a **Current Ratio** supported by its liquid investment portfolio. --- ### **Strategic Leadership & Governance Framework** The company is currently focused on leadership continuity and aligning with modern corporate governance standards. **Board Composition and Tenure:** * **Mr. Rajesh Batra (Managing Director):** Secured a **3-year** extension from **June 1, 2025, to May 31, 2028**. Notably, the board approved his continuation beyond the age of **70 years** to ensure stability. * **Ms. Rina Suresh Deora (Independent Director):** Appointed for a **5-year term** (May 2025 – May 2030) to enhance oversight and ensure compliance with **SEBI Listing Regulations**. * **Mr. Divakar G. Kamath (Executive Director & CFO):** Re-appointed in **May 2023** to maintain financial continuity. The company operates with a lean domestic workforce of **8 permanent employees**, reflecting its transition into a trading and holding-focused entity. --- ### **Risk Profile & Mitigation Strategies** #### **1. Market and Macroeconomic Risks** * **Global Demand:** Muted demand from the **USA and Europe** due to geopolitical tensions in **Eurasia and the Middle East** poses a risk to the garment export and international brand segments. * **Technological Shift:** The company identifies **Artificial Intelligence (AI)** as a disruptive force in consumer preference mapping, requiring new expertise. * **Currency Volatility:** Exposure to **GBP/USD/INR** fluctuations is managed through **forward contracts** to hedge imports and exports related to the FILA brand. #### **2. Financial and Credit Risks** * **Credit Exposure:** Trade receivables are generally **unsecured** with credit periods of **30 to 180 days**. This is mitigated through strict credit limits and monitoring. * **Interest Rates:** The company has **zero exposure** to interest rate risk due to its debt-free status. #### **3. Legal and Contingent Liabilities** Cravatex is managing several legacy legal matters: * **Provident Fund Dispute:** A pending review petition following a **2019 Supreme Court** ruling on wage allowances. While the impact since 2019 is deemed insignificant, past liabilities remain "not ascertainable." * **Tax Litigation:** Includes a **Wealth Tax** dispute of **Rs. 51.25 Lacs** (deposited under protest) and an **Income Tax** demand of **Rs. 16.43 Lacs** for AY 2013-14 currently under appeal. * **Customs:** A **Rs. 1.20 crore** bond remains in force pending the finalization of import values. --- ### **Operational Infrastructure** * **Registered Office:** In **November 2023**, the company moved its headquarters to **1st Floor, Godrej Bhavan, 4A Home Street, Fort, Mumbai**. * **R&D:** The company incurs **no expenditure** on Research & Development and does not utilize imported technology, focusing instead on brand licensing and trading efficiency. * **Internal Controls:** Financial systems are audited by an independent firm of Chartered Accountants to ensure adequacy and regulatory compliance.